The Association of 3-Hydroxy-3-Methylglutaryl-CoA Reductase, Apolipoprotein E, and Solute Carrier Organic Anion Genetic Variants with Atorvastatin Response among Jordanian Patients with Type 2 Diabetes

The Influence Of Endothelial Nitric Oxide Synthase (Enos) Genetic Polymorphisms On Cholesterol Blood Levels Among Type 2 Diabetic Patients On Atorvastatin Therapy

(2020) Sarah Abdullah et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

(2019) Donna K. Arnett et al.   CIRCULATION

Pharmacogenetics of statins treatment: Efficacy and safety

(2019) Zi‐Wan Guan et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice

(2018) Yazun Jarrar et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Comparison of three genomic DNA extraction methods to obtain high DNA quality from maize

(2017) Amani Abdel-Latif et al.   Plant Methods

APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects

(2015) Jenny Lagos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

GenBank

(2013) Dennis A. Benson et al.   NUCLEIC ACIDS RESEARCH

How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?

(2012) Patricia Maningat et al.   Current Atherosclerosis Reports

Pharmacogenomics

(2011) Dan M. Roden et al.   CIRCULATION

Pharmacogenetics of drug-induced liver injury

(2010) Stefan Russmann et al.   HEPATOLOGY

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

(2008) W. Ray Kim et al.   HEPATOLOGY

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE